Article Text

Download PDFPDF

Review
A practical guide to thiopurine prescribing and monitoring in IBD
  1. Ben Warner1,
  2. Emma Johnston2,
  3. Monica Arenas-Hernandez3,
  4. Anthony Marinaki3,
  5. Peter Irving2,
  6. Jeremy Sanderson2
  1. 1 1st Floor College House, St Thomas’ Hospital, London, UK
  2. 2 Department of Gastroenterology, Guy's and St Thomas’ NHS Foundation Trust, London, UK
  3. 3 Purine Laboratory, Viapath, St Thomas’ Hospital, London, UK
  1. Correspondence to Dr Ben Warner, 1st Floor College House, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK; B.warner{at}uclmail.net

Abstract

Thiopurines are often the mainstay of treatment for many patients with inflammatory bowel disease. As such, a general understanding of the evidence behind their use and of their metabolism is extremely useful in clinical practice. This review gives a practical overview of thiopurine metabolism, the importance of thiopurine S-methyltransferase testing prior to the start of therapy and the monitoring of thioguanine nucleotide levels while on treatment, guiding a personalised approach to optimising thiopurine therapy.

  • AZATHIOPRINE
  • 6-MERCAPTOPURINE
  • INFLAMMATORY BOWEL DISEASE
  • THIOPURINE METHYLTRANSFERASE
  • ADVERSE DRUG REACTIONS

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.